Physician profile

Sandhya Bassin

Endocrinology, Diabetes & Metabolism · Old Bridge, NJ

NPI 1831650555

$877.63

in general payments reported to CMS, 2019-2025

15 companies · $755 in 2025

The $755 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$792.63
Gift$42.50
Education$42.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $193.80 2024-2025 Ozempic, Rybelsus, Wegovy
Abbott Laboratories $102.75 2025 Freestyle Libre 3
Mannkind Corporation $101.76 2024-2025
Corcept Therapeutics $85.08 2025 Korlym
Dexcom, INC. $83.47 2025 Dexcom G6 Transmitter
Lilly USA, LLC $51.28 2024-2025 Mounjaro, Zepbound, Jardiance
Bayer Healthcare Pharmaceuticals INC. $44.57 2025
Xeris Pharmaceuticals, INC. $41.65 2025 Recorlev
Medtronic, INC. $36.46 2025 Minimed 780g
Insulet Corporation $32.42 2024-2025 Omnipod
Tandem Diabetes Care, INC. $31.24 2025 T:Slim X2 Insulin Pump With Control-Iq
Beta Bionics, INC. $23.02 2025 Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach
Amgen INC. $17.69 2025 Repatha
Madrigal Pharmaceuticals $16.80 2025 Rezdiffra
Boehringer Ingelheim Pharmaceuticals, INC. $15.64 2025 Jardiance

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sandhya Bassin

$877.63

in general payments reported 2019-2025

Years
2024-2025
Top company
Novo Nordisk INC
Context
The $755 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

https://glasscript.com/doctor/11645932/sandhya-bassin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.